Fresenius SE & Co. KGaA (FSNUY)

Market Cap	31.16B
Revenue (ttm)	26.33B
Net Income (ttm)	1.34B
Shares Out	n/a
EPS (ttm)	2.38
PE Ratio	23.23
Forward PE	12.97
Dividend	0.19 (1.38%)
Ex-Dividend Date	May 27, 2025

Volume	13,539
Average Volume	30,856
Open	14.05
Previous Close	13.95
Day's Range	13.81 - 14.05
52-Week Range	8.49 - 33.93
Beta	0.92
RSI	45.16
Earnings Date	Mar 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1912
• Employees: 176,486
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSNUY

Financial Performance

Financial numbers in EUR